| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/11/2010 | US20100063099 Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens |
| 03/11/2010 | US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators |
| 03/11/2010 | US20100063069 Gyrase inhibitors and uses thereof |
| 03/11/2010 | US20100063067 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/11/2010 | US20100063061 Antibacterial quinoline derivatives |
| 03/11/2010 | US20100063059 Novel pyridazine compound and use thereof |
| 03/11/2010 | US20100063046 Tetracyclic imidazole analogs |
| 03/11/2010 | US20100063026 Antibacterial quinoline derivatives |
| 03/11/2010 | US20100063023 Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors |
| 03/11/2010 | US20100063020 Oral pharmaceutical formulations and methods for producing and using same |
| 03/11/2010 | US20100063010 Method for administering a spill resistant pharmaceutical system |
| 03/11/2010 | US20100063008 Gelatinous elastomer compositions |
| 03/11/2010 | US20100063005 Methods for Treating Cystic Fibrosis or Pneumonia with Bacterial Infection via Pulmonary Administration of Fosfomycin |
| 03/11/2010 | US20100063004 Topical pharmaceutical composition |
| 03/11/2010 | US20100062974 Combination therapy for the treatment of bacterial infections |
| 03/11/2010 | US20100062968 Novel strategies for delivery of active agents using micelles and particles |
| 03/11/2010 | US20100062083 Dermal film-forming liquid formulations for drug release to skin |
| 03/11/2010 | US20100062071 Particle Formulations and Uses Thereof |
| 03/11/2010 | US20100062069 Process for preparing particles containing an antiviral |
| 03/11/2010 | US20100062055 Lipid-based nitric oxide donors |
| 03/11/2010 | US20100062047 Composition for Administration to Mammals or Human |
| 03/11/2010 | US20100062044 Method and a product to reduce and treat problems associated with tinea pedis |
| 03/11/2010 | US20100062042 Methods, Systems and Devices for Administration of Chlorine Dioxide |
| 03/11/2010 | US20100062027 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 03/11/2010 | US20100062024 Biologically Active Hemagglutinin From Type A Clostridium Botulinum and Methods of Use |
| 03/11/2010 | US20100062022 Immunogenic proteins of burkholderia pseudomallei and uses thereof |
| 03/11/2010 | US20100062019 New vaccine formulations |
| 03/11/2010 | US20100062018 Mycoplasma hyopneumoniae bacterin vaccine |
| 03/11/2010 | US20100062017 Pasteurella multocida vaccine |
| 03/11/2010 | US20100062015 Fusion protein vaccine |
| 03/11/2010 | US20100062009 for cancer, immune, infectious and ischemic diseases; inhibiting tumor growth; allergy |
| 03/11/2010 | US20100061995 Immunotherapy To Treat Or Prevent Viral Infection |
| 03/11/2010 | US20100061991 Identification of therapeutic agents for HIV infection |
| 03/11/2010 | US20100061985 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 03/11/2010 | US20100061961 Recombinant super-compound interferon |
| 03/11/2010 | US20100061960 Amido Anti-Viral Compounds, Compositions, And Methods Of Use |
| 03/11/2010 | US20100061957 Hpv-16-based papillomavirus vaccines |
| 03/11/2010 | DE102008046610A1 Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt Use of a pharmaceutical composition for local infection therapy and medical device |
| 03/11/2010 | CA2736151A1 Outer membrane vesicle prime - protein boost vaccine |
| 03/11/2010 | CA2736134A1 Lps based vaccines |
| 03/11/2010 | CA2736030A1 Method of inducing an anti-viral immune response |
| 03/11/2010 | CA2736029A1 Anti-lipid antibodies |
| 03/11/2010 | CA2735926A1 Pharmaceutical composition for use in treating sexually transmitted infections |
| 03/11/2010 | CA2735875A1 Use of quinazoline derivatives for the treatment of viral diseases |
| 03/11/2010 | CA2735811A1 Compositions and methods for inhibiting entry of a hepatic virus |
| 03/11/2010 | CA2735793A1 Antiviral agent |
| 03/11/2010 | CA2735783A1 Nucleoside derivatives as inhibitors of viral polymerases |
| 03/11/2010 | CA2735420A1 Macrocyclic pyrimidines as protein kinase inhibitors |
| 03/11/2010 | CA2735229A1 Combination therapy for tuberculosis |
| 03/11/2010 | CA2735175A1 Antimicrobial protein compositions and production therefor from marine bacteria |
| 03/11/2010 | CA2735008A1 Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor |
| 03/11/2010 | CA2734392A1 Organic compounds |
| 03/11/2010 | CA2733943A1 Peptides presenting an epitope of an a domain of factor h binding protein and methods of use |
| 03/11/2010 | CA2733671A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 03/11/2010 | CA2732338A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen |
| 03/10/2010 | EP2161329A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof |
| 03/10/2010 | EP2161285A1 Monoclonal antibodies for neutralizing anthrax toxin |
| 03/10/2010 | EP2161279A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies |
| 03/10/2010 | EP2161268A1 Carbacephem beta-lactam compounds for the treatment of bacterial infections |
| 03/10/2010 | EP2161267A1 A process for stereoselective synthesis of lamivudine |
| 03/10/2010 | EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 03/10/2010 | EP2161035A1 Bordetella parapertussis-containing whole-cell vaccine composition |
| 03/10/2010 | EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof |
| 03/10/2010 | EP2160466A1 Treatment and prevention of influenza |
| 03/10/2010 | EP2160394A1 Tenofovir disoproxil hemi-fumaric acid co-crystal |
| 03/10/2010 | EP2160392A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/10/2010 | EP2160221A1 Cyclic peptide cxcr4 antagonists |
| 03/10/2010 | EP2046378B1 Use of bacterial polysaccharides for biofilm inhibition |
| 03/10/2010 | EP1641474B1 Therapeutical composition containing dentritic cells and use thereof |
| 03/10/2010 | EP1554586B1 Identification of drugs against mycobacteria |
| 03/10/2010 | EP1511752B3 Camptothecins with a modified lactone ring |
| 03/10/2010 | EP1423376B1 Bicyclic compound, production and use thereof |
| 03/10/2010 | EP1313699B1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 03/10/2010 | CN101664388A transnasal transport/immunisation with highly adaptable carriers |
| 03/10/2010 | CN100593544C Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 03/09/2010 | US7674903 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 03/09/2010 | US7674898 Anhydrous crystal of β-lactam compound and method for preparation thereof |
| 03/09/2010 | US7674888 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 03/09/2010 | US7674830 Reducing blood glucose concentrations, weight loss, and treating diseases and conditions mediated by the cyclooxygenase-2 and 5-lipoxygenase enzymes; an enzyme inhibitors |
| 03/09/2010 | US7674823 DNA-PK inhibitors |
| 03/09/2010 | US7674777 Immunostimulatory nucleic acid molecules |
| 03/09/2010 | US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/09/2010 | US7674769 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI) |
| 03/09/2010 | US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis |
| 03/09/2010 | CA2399813C Indol-3-yl derivatives |
| 03/05/2010 | CA2679676A1 Monoclonal antibodies for neutralizing anthrax toxin |
| 03/05/2010 | CA2654756A1 Vaccination for lawsonia intracellularis |
| 03/04/2010 | WO2010025469A1 West nile virus vaccine |
| 03/04/2010 | WO2010025448A2 Inhibition of cell proliferation |
| 03/04/2010 | WO2010025438A2 Methods of treatment using single doses of oritavancin |
| 03/04/2010 | WO2010025322A2 Magnetic nanodelivery of therapeutic agents across the blood brain barrier |
| 03/04/2010 | WO2010025267A2 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase |
| 03/04/2010 | WO2010025201A1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. |
| 03/04/2010 | WO2010024676A1 Delivery of a cd40 agonist to a tumor draining lymph node of a subject |
| 03/04/2010 | WO2010024405A1 Ifn type-1 production inhibitor and method for searching for same |
| 03/04/2010 | WO2010024384A1 Anti-hepatitis c virus composition |
| 03/04/2010 | WO2010024356A1 Novel hydroxamic acid derivative having naphthyridine-n-oxide |
| 03/04/2010 | WO2010024284A1 Anti-viral vaccine for fish, immunostimulating agent for fish, and immunostimulation method for fish |
| 03/04/2010 | WO2010024225A1 Novel dihydrotriazine derivative |
| 03/04/2010 | WO2010024108A1 Prophylactic or therapeutic agent for influenza virus infection |